Clinical Trials Browser

Phase 1/2 × NIH × aflibercept × Clear all

NCT00436501 2019-02-26

VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Phase 1/2 Completed

58 enrolled 16 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms